title: [Integration to school of young children with type 1 diabetes on insulin pump therapy: parent's feed-back].
abstract: There is an increase in the incidence of type 1 diabetes (T1D) in children younger than 5 years of age and continuous subcutaneous insulin infusion (CSII) appears to be an increasingly popular therapeutic option in France. A retrospective self-evaluation questionnaire was distributed to parents of young children with T1D treated by CSII (42 children, age 4.8±1.0 years, 2.3±0.5 years at the onset of TD1, mean± SD). It focused on the quality of diabetes management in daycare centers or with nannies and at school. Parental satisfaction related to the management of their children was overall good (84% for all the parents, 70.5% for the parents of children at nursery-school, from 3 to 6 years. However 93% of the parents experienced and overcame serious difficulties: exclusion of the children on account of DT1 (school trips, daycare centers after school), use of the pump for lunch and snacks, realization of glycemic controls, participation in school trips, survey during school meals. In spite of these difficulties these young children had a normal and safe time at school. The management of the young children with DT1, treated by CSII, in alternate care centers and at school need to be improved; the experience was positive when daycare workers and teachers agreed to be instructed.
authors.affiliation: Service de pédiatrie, centre hospitalier intercommunal de Poissy-Saint-Germain-en-Laye, 10, rue du Champ-Gaillard, 78300 Poissy, France. Electronic address: crosnier.hjj@orange.fr.
authors.forename: H
authors.initials: H
authors.lastname: Crosnier
authors.affiliation: Service d'endocrinologie et de diabétologie pédiatrique, hôpital Robert-Debré (AP-HP), 48, boulevard Sérurier, 75019 Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Tubiana-Rufi
mesh_terms: D002648:Child; D002675:Child, Preschool; D062309:Community Integration; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D008297:Male; D010290:Parents; D017060:Patient Satisfaction; D012189:Retrospective Studies; D012574:Schools
chemical_list: D007328:Insulin